Lab-grade biomaterial scaffolds, made in India

Your research doesn't wait
6 weeks for a scaffold.

Bioscafil manufactures custom 3D-printed biomaterial scaffolds for tissue engineering, drug delivery, and in-vitro drug screening — delivered in 2 weeks at up to 60% lower cost than imported alternatives.

2 weeks Average lead time
60% Cost savings vs. imports
100% Made in India
Book a 15-min call →

Academic researchers in India are paying through the nose for imported scaffolds.

6–8

weeks lead time from international suppliers

3–5×

more expensive due to import duties, shipping, and distributor margins

0

India-based scientific support — time zone mismatch, generic responses

×

custom geometries delayed by procurement bureaucracy

India's biotech sector produces world-class research. Its supply chain for research materials hasn't kept up.

Scientist-to-scientist. Built in India. Built for your research.

01

Custom geometry, any material

Porosity, pore size, mechanical strength, material composition — designed to your exact specification, not an off-the-shelf catalog.

02

2-week turnaround

From design approval to delivery at your lab in 2 weeks. No international shipping delays. No customs documentation.

03

Up to 60% lower cost

Domestic manufacturing eliminates import duties, freight, and distributor margins. Quality without the premium.

04

Peer-level consultation

Talk to scientists who understand your research — not a sales rep reading from a datasheet. We speak tissue engineering.

05

Publication support

Characterization data, material certificates, and methodology documentation included. Built for peer-reviewed research.

06

Contract research capability

Need a drug screening run or custom assay development? We offer scaffold-based contract research as a standalone service.

Scaffolds for every application in regenerative medicine and drug research.

Tissue Engineering

Bone, cartilage, skin, and neural tissue scaffolds with controlled degradation profiles and mechanical properties matching native tissue.

Drug Delivery

Release profiles tuned to your research — diffusion-controlled, swell-controlled, or biodegradable matrices for targeted delivery studies.

In-Vitro Drug Screening

3D cell culture platforms and organoid scaffolds for high-throughput drug response testing. Reduce assay costs with lab-made constructs.

Wound Healing

Biomaterial wound matrices with controlled moisture management, drug loading capability, and degradable backing for burns and chronic wounds.

Cancer Research

Tumor-mimicking scaffolds for 3D oncology models. Co-culture platforms combining cancer cells with stromal components for mechanistic studies.

Organoid Research

Precision scaffolds for patient-derived organoid models. Compatible with stem cell culture protocols and live-cell imaging systems.

Built for researchers who need results, not procurement delays.

Bioscafil was built for the scientists doing the most demanding work in Indian biotech — researchers who can't afford to wait 8 weeks for a scaffold from the US, who need custom geometries that catalog products can't provide, and who need a manufacturing partner who speaks their language.

  • IITs & IISc — tissue engineering labs, biomaterials groups, bioengineering departments
  • AIIMS & medical colleges — regenerative medicine, surgical research, oncology
  • Pharma R&D — drug delivery systems, 3D tumor models, absorption studies
  • CROs & biotech startups — contract research, proof-of-concept builds, BIRAC-funded projects
  • NIPERs & CSIR labs — advanced therapy research, nanocarrier scaffolds

"The moment you stop importing is the moment your research timeline becomes yours again."

— Bioscafil founding principle

From idea to scaffold in your lab — in 2 weeks.

01

Consultation

Share your research requirements — target tissue, cell type, mechanical specs, degradation timeline. We review and confirm feasibility within 48 hours.

02

Design & Proof

We model your scaffold in CAD, simulate key parameters, and share a design proof for your sign-off. Adjustments are included in the project fee.

03

Manufacture

3D printing with your specified biomaterial — PLA, PCL, chitosan, alginate, HA composites, or custom formulations. Quality-controlled at every stage.

04

Delivery

Packaged for lab use, shipped to your institution with characterization data, material certificates, and a technical report for your methods section.

India is building a $300 billion bioeconomy by 2030. Researchers who move fastest will shape it.

The gap between what Indian scientists need and what's available domestically is the biggest opportunity in advanced biomaterials today. Every week saved on procurement is a week of data generated, a paper closer to submission, a grant milestone hit.

Bioscafil is the manufacturing partner for that future.